Jennifer Avise, MD
Vascular Surgery · Pleasanton, CANPI 1801039615
Payments from drug & device makers
Across 167 payments — averaging $207.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alphatec Spine, Inc$24K
- Medtronic$3K
- Bard Peripheral Vascular, Inc.$2K
- Globus Medical$2K
- Silk Road Medical, Inc.$2K
- Shockwave Medical, Inc$387
- plus $717 from 7 others
What the payments were for
- Consulting fees$16,00046%
- Travel & lodging$12,84037%
- Food & beverage$5,73417%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alphatec Spine, Inc | 29 | $24,402 |
| Medtronic(2 entities) | 51 | $3,136 |
| Bard Peripheral Vascular, Inc. | 46 | $2,377 |
| Globus Medical | 15 | $1,870 |
| Silk Road Medical, Inc. | 8 | $1,720 |
| Shockwave Medical, Inc | 5 | $387 |
| Penumbra, Inc. | 3 | $270 |
| Boston Scientific | 3 | $150 |
| W. L. Gore & Associates, Inc. | 2 | $124 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $96 |
| Smith+Nephew | 2 | $41 |
| Cook Medical LLC | 1 | $21 |
| Walk Vascular, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Solus ALIF$16,000
- Other - Miscellaneous$7,978
- ENROUTE Transcarotid Neuroprotection System$1,690
- ENROUTE Transcarotid Stent$1,569
- HawkOne$972
- ALIF$947
- PIVOX Oblique Lateral Spinal System$296
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$240
- Crosser iQ$158
- Valiant Captivia$152
- Indigo System$149
- VIABAHN VBX Balloon Expandable Endoprosthesis$122
- ENDURANT IIS$120
- LUTONIX$104
- LifeStent Solo Vascular Stent$103
How this compares
$34,609 in reported general payments places this provider in the 80th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $145 |
| ClopidogrelClopidogrel Bisulfate | 34 | $70 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Pleasanton
- Venita ChandraPalo Alto$947K
- Leigh Ann ObanionFresno$932K
- Sukgu HanLos Angeles$765K
- Mahmoud Malasla Jolla$508K
- Son DuongFountain Valley$503K
- Leo FongClovis$496K
- Jason LeePalo Alto$403K
- Bernardo Curi MendesLos Angeles$376K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.